Satellos Bioscience Inc. ( MSLE) - Key Metrics
MSLE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.55 | -$0.38 | -$0.38 |
| 2026Q1 | $0 | -$0.53 | -$0.51 | -$0.51 |
| 2025Q4 | $0 | -$0.47 | -$0.47 | -$0.47 |
| 2025Q3 | $0 | -$0.42 | -$0.30 | -$0.30 |
| 2025Q2 | $0 | -$0.39 | -$0.34 | -$0.34 |
MSLE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.54 |
| 2026Q1 | 0% | -2.66 |
| 2025Q4 | 0% | -3.69 |
| 2025Q3 | 0% | -4.92 |
| 2025Q2 | 0% | -4.92 |
MSLE
Price: $9.55
52 week price:
Earnings Per Share: -1.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 11.6 million